Measured market calls for private investors.
Investors' Chronicle treats market news as a chain of practical implications, from takeover approaches and spin-offs to energy shocks and retirement products. Its rotating conversations favor valuation, cash flow, sector exposure and investor risk over headlines alone.
PRESS PLAY
Investors' Chronicle is a steady, analyst-led guide to the questions behind market news. It is less interested in the headline move than in what the move implies. A rejected bid, a spin-off, a share-price surge or a war-driven commodity shock becomes the starting point for a discussion about earnings, assets, cash generation and valuation. The Companies and Markets episodes have a clear rhythm. A company or sector is framed, a specialist is brought in, and the conversation moves through the operational details that might matter to shareholders. Recent examples include Intertek's board changes and strategic review, Unilever's planned food-business disposal to McCormick, Berkeley's unscheduled update, and Raspberry Pi's sharp share-price reaction after results. The show also follows the effect of geopolitics on investors. The US-Israeli war with Iran, the Strait of Hormuz, gas prices, electricity prices, fertiliser and helium all appear as market inputs rather than abstractions. That can make the tone grave, but it stays controlled. Fund and personal finance episodes widen the lens. A conversation with Jacob de Tusch-Lec focuses on global income, dividend yield, free cash flow and diversified holdings. Women and Wealth covers student loans through repayment rules, debt levels and the uneven effect on women's finances. Annuities, retirement stability and rising bond yields are treated with similar caution. The show is strongest when it turns complexity into an investment checklist: who is exposed, what has already been priced in, where the cash flow comes from, and what uncertainty remains. It assumes listeners can handle technical terms, but it usually gives enough context to keep the discussion usable. The result is a practical market desk in podcast form, suited to private investors who want careful judgment, company specifics and macro context in the same conversation.
Made for: For financially literate private investors who follow UK-listed companies, funds, trusts and personal finance decisions. It suits listeners who want caveats, figures and sector context rather than quick trading slogans.
What sets it apart: The show links company-specific reporting with macro pressure, portfolio construction and investor mechanics. It stands out by asking whether the current price already reflects the risk.
Looking to stay informed in the world of investing? Investors' Chronicle dives into the key trends shaping today’s markets and unpacks what they mean for your investments. Featuring exclusive interviews with professional investors - whether fund managers or leading financial experts - our mission is to help you make smarter investment decisions. Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Our
Based on 6 episodes we listened to · September 2026
Company results, portfolio decisions and market mechanics receive the same disciplined attention, making complex investment cases easier to assess.
Investors' Chronicle moves between company-level scrutiny, market context and the mechanics of investing. Dan Jones guides discussions of listed businesses and sector shifts, while Val Cipriani's interview with Sean Peche tests a fund manager's valuation discipline through…
Jet2 and Optima Health fall after results, and you get more than a shrug.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A clear tour of corporate upheaval, power-price exposure and a fast-rising microfinance share.
Intertech's busy week gives Companies & Markets a useful test of how corporate news feeds into an investment case. Board changes, a strategic review and a rejected private-equity bid arrive in quick succession, and the episode treats them as connected parts of the testing,…
Industrial updates meet the hidden machinery of UK trade execution, ending with a cautious real estate note.
This Companies and Markets Show links industrial stock picking to the market structure sitting underneath it. Diploma gets the sharper near-term focus after its latest trading update and a share price jump, while Accenture is framed as a longer-running turnaround story, with…
A market update that stays practical when the world gets louder.
The episode starts with war in the Middle East, oil at $110 a barrel, and stocks under pressure, then turns that market noise into plain action: John Lee has taken some profits, sold some M&G and Goodwins, and nudged cash higher.
A measured PlayNext briefing on Iran-linked energy pressure, healthcare earnings and the practical trade-offs around ISA choices.
PlayNext sets a company-results day against market focus on the US-Israel war with Iran, opening with attacks on Iran, responses across the Middle East and a sharp rise in energy prices.
A value manager explains how small positions, early exits and an Alphabet bet shaped his approach.
Value investing gets a practical workout here, centered on a fund that grew from about $300 million in assets in June 2024 to about $2.3 billion by January.
Inheritance-tax timing sits alongside live questions around AstraZeneca, GSK and Serra's Power.
The Companies and Markets Show frames the Great Wealth Transfer as a matter of timing, control and family trade-offs, then sets that alongside two company stories still in motion.
A clear, measured review of two pressured AIM shares, led by Optima's contract-led growth story and funding caveat.
Two AIM-listed businesses set the shape of a Companies and Markets Show caught between solid operating updates and softer share prices. Dan Jones brings in Jet2 after its full-year figures and Optima Health after annual results, with Mike Fahey and Julian Hoffman weighing stocks…
Leadership lessons from systems under strain.
Executive strategy, from inside the boardroom.
The Companies and Markets Show analyzes two AIM-listed stocks: Jet2, whose shares fell despite a 15% revenue increase, and Optima Health, which reported maiden results after spinning off from Marlowe.
This episode analyzes AstraZeneca's US listing shift and expedited cancer drug review, alongside GSK's CEO transition.
Intertek opens the market agenda after board changes, a strategic review, and a rejected private equity bid offer.
This episode analyzes the US-Iran ceasefire's impact on global markets, explores investment opportunities in Africa amid energy challenges, and evaluates the takeover approach for engineering company Senior.
This episode analyzes Unilever's $45 billion spinoff of its food business to McCormick, Barclay's unscheduled update on house building, and Raspberry Pi's stock surge amid the AI boom.
This episode features an interview with Jakob de Tuschleck, fund manager of the Artemis Global Income Fund, discussing the fund's global investment strategy focused on dividend-paying companies and portfolio diversification.
This episode analyzes market impacts from the US-Israeli war with Iran, focusing on the Strait of Hormuz disruption, UK company Goodwin's struggles, and annuity considerations amid uncertainty.
This episode discusses the student loan system, its financial burden on graduates, why changes are being demanded, and how it disproportionately affects women.
The show opens with industrials.
Alex Newman opens on March 9 with all-out war in the Middle East, oil at $110 a barrel, and stocks under pressure.
The Companies and Markets Show begins with the market consequences of the US and Israel's attacks on Iran.
Sean Peche of Ranmore Global Equity tells Val Cipriani why he thinks "buy and hold forever" is a fallacy and why his favorite holding period is a day.
This episode discusses BP's CEO change and strategy shift, the commodities outlook, diversification in asset allocation, and Auction Technology's recent bids.
This episode of the Companies and Markets Show covers market news including Bitcoin's resurgence, Volution's performance in industrial ventilation, and CVS's regulatory developments in veterinary services.
This episode analyzes AstraZeneca's US-UK developments, Ceres Power's financial outlook, and practical strategies for intergenerational wealth transfer.
This episode of The Companies and Markets Show covers Centrica's involvement in the Sizewell C nuclear project, global hidden gem stocks excluding the US, and a comparison of Coca-Cola and PepsiCo's diverging share prices.